Side-by-side comparison of AI visibility scores, market position, and capabilities
Clinically validated XR therapeutic applications with FDA 510(k) clearances for rehabilitation and mental health. Boston MA; founded 2016; covers stroke recovery, TBI, Parkinson's, autism, and PTSD; prescribable by licensed clinicians and billable through health insurance plans.
XRHealth is a digital therapeutics company headquartered in Boston, Massachusetts, that develops clinically validated extended reality (XR) applications for medical rehabilitation and mental health treatment. Founded in 2016, XRHealth holds FDA 510(k) clearances for several of its XR therapeutic applications, a distinction that separates it from general wellness VR products and enables its applications to be prescribed by licensed clinicians and billed through health insurance. The company's platform spans rehabilitation for neurological conditions (stroke recovery, traumatic brain injury, Parkinson's disease), musculoskeletal rehabilitation, and cognitive and mental health interventions, all delivered through consumer-grade VR headsets in clinical settings or the patient's home.\n\nXRHealth's platform combines therapeutic XR applications with a clinical intelligence layer that captures patient performance data during each session—motion range, reaction time, cognitive accuracy, and engagement metrics—and presents it through a clinician portal for remote monitoring and treatment plan adjustment. This telehealth-integrated model enables physical therapists, occupational therapists, and neurologists to prescribe XR therapy programs and monitor patient progress asynchronously, extending the reach of rehabilitation services beyond clinic walls. The company partners with hospital systems, rehabilitation centers, and insurance providers to integrate XR therapy into standard care pathways.\n\nXRHealth competes with AppliedVR, Penumbra's REAL System, and MindMaze in the clinical XR therapeutics market. Its FDA-cleared product portfolio, insurance reimbursement progress, and clinician-facing data platform distinguish it from consumer wellness VR tools and position it as a credentialed medical technology company. For healthcare providers and payers seeking technology-enabled rehabilitation solutions that can demonstrate clinical outcomes and integrate into existing care management workflows, XRHealth offers one of the most clinically validated XR therapy platforms commercially available.
US #2 sports betting operator with 35.3% market share; Q3 2025 revenue $1.14B; ESPN's exclusive sports-betting partner since Nov 2025; listing on Nasdaq; differentiated through same-game parlays, DraftKings Network media, and Dynasty Rewards loyalty.
DraftKings is a Boston-based digital sports entertainment and gaming company founded in 2012 by Jason Robins, Matthew Kalish, and Paul Liberman. Originally a daily fantasy sports platform, DraftKings pivoted following the 2018 Supreme Court PASPA ruling to become a full-service sportsbook and online casino operator. The company went public via SPAC merger in 2020 and now operates in 25+ states with online sports betting and in 7+ states with online casino products, under the DraftKings Sportsbook and DraftKings Casino brands.\n\nDraftKings has built product differentiation through its same-game parlay features, in-play betting markets, and the DraftKings Marketplace (an NFT-adjacent digital collectibles platform). Its loyalty program, Dynasty Rewards, and the DraftKings Network media content strategy help drive organic player acquisition. The company's ESPN partnership—announced as an exclusive sports-betting integration in November 2025—gives it access to ESPN's 75 million monthly unique visitors across linear TV and digital.\n\nDraftKings reported Q3 2025 revenue of $1.144B, with full-year 2025 revenue on track for approximately $4.5B+. The company holds approximately 35.3% of the U.S. sports betting market by gross gaming revenue, second only to FanDuel's 39.6%. DraftKings continues to invest in customer acquisition while targeting EBITDA profitability at scale.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.